ACHV

Peers: AXSM AZR PHAT VNDA ACOG RLMD TNXP HELP CING MNOV

| Held by: VTI XBI IWM VXF SURI IWO VTWO FESM IWC VFMO

Index	RUT
Market Cap	683.27M
Enterprise Value	510.92M
Income	-114.04M
Sales	0.00M
Book/sh	-0.14
Cash/sh	1.82
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	28
IPO	Oct 12, 1995

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	3.65
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.95
Current Ratio	0.95
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-1.55
EPS next Y	-0.68
EPS next Q	-0.20
EPS this Y	-16.80%
EPS next Y	53.58%
EPS next 5Y	-
EPS past 3/5Y	32.06% 25.38%
Sales past 3/5Y	- -
EPS Y/Y TTM	-6.14%
Sales Y/Y TTM	-
EPS Q/Q	-118.05%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	-385.14% -

Insider Own	32.16%
Insider Trans	-0.06%
Inst Own	55.95%
Inst Trans	49.74%
ROA	-91.46%
ROE	-844.99%
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-2.98%
SMA50	-10.58%
SMA200	17.60%
Trades

Shs Outstand	102.72M
Shs Float	69.81M
Short Float	25.51%
Short Ratio	12.30
Short Interest	17.81M
52W High	8.64 -23.15%
52W Low	2.62 153.44%
Volatility	6.14% 5.79%
ATR (14)	0.41
RSI (14)	43.11
Beta	2.43
Rel Volume	0.90
Avg Volume	1.45M
Volume	1,292,029

Perf Week	1.53%
Perf Month	-8.29%
Perf Quarter	2.63%
Perf Half Y	51.25%
Perf YTD	33.60%
Perf Year	29.69%
Perf 3Y	54.42%
Perf 5Y	-22.79%
Perf 10Y	-99.18%
Recom	1.00
Target Price	14.58
Prev Close	6.83
Price	6.64
Change %	-2.78%

Consensus

Strong Buy

Avg. Price Target

$14.58

Implied Upside

+119.6%

Analysts9incl. previous ratings

Rating Distribution9 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 30, 2026	Initiated	SStifel	Buy	$18	+171.1%
Aug 13, 2026	Initiated	MMorgan Stanley	Overweight	$13	+95.8%
Jun 26, 2026	Resumed	RRaymond James	Strong Buy	$20	+201.2%
Apr 21, 2026	Initiated	CCanaccord Genuity	Buy	$13	+95.8%
Nov 25, 2025	Initiated	CCitizens JMP	Mkt Outperform	$19	+186.1%
Aug 21, 2025	Initiated	HH.C. Wainwright	Buy	$12	+80.7%
Nov 14, 2024	Initiated	RRodman & Renshaw	Buy	$12	+80.7%
Sep 27, 2024	Initiated	RRaymond James	Strong Buy	$20	+201.2%
May 10, 2023	Reiterated	MMaxim Group	Buy	$8 → $20	+201.2%
Jun 23, 2021	Initiated	OOppenheimer	Outperform	$23	+246.4%

Today 08:30AM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
Oct-21-26 08:30AM	Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026 (GlobeNewswire)
Oct-15-26 08:41AM	Lisata adds biopharma finance veteran Jeffrey Farrow to board (Proactive)
Oct-07-26 08:30AM	Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications (GlobeNewswire)
Oct-06-26 04:02PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
08:30AM	Loading…
Oct-01-26 08:30AM	Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer (GlobeNewswire) -6.92%
Sep-28-26 08:30AM	Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026 (GlobeNewswire)
Sep-03-26 05:15PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Aug-11-26 08:30AM	Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-03-26 08:30AM	Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality (GlobeNewswire)
Jul-31-26 08:30AM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Jun-29-26 08:30AM	Achieve Life Sciences Joins Russell 2000 Index (GlobeNewswire)
Jun-22-26 08:30AM	Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA (GlobeNewswire) +5.15%
Jun-02-26 08:30AM	Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors (GlobeNewswire) -5.09%
May-19-26 02:15PM	Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment (GlobeNewswire) -6.71%
07:04PM	Loading…
May-12-26 07:04PM	Achieve Life Sciences Inc (ACHV) Q1 2026 Earnings Call Highlights: Strategic Financing and ... (GuruFocus.com) +7.16%
07:05AM	Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma (GlobeNewswire)
07:00AM	Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates (GlobeNewswire)
May-05-26 08:30AM	Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026 (GlobeNewswire)
Apr-16-26 08:57AM	Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors (GlobeNewswire) +35.49%
08:53AM	Achieve Life Sciences Announces Up to $354 Million Private Placement (GlobeNewswire)
Apr-15-26 08:00AM	Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions (GlobeNewswire)
Mar-26-26 08:30AM	Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability (GlobeNewswire)
Mar-24-26 03:02PM	Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com) -28.40%
02:23PM	Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (Newsfile)
07:00AM	Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-17-26 08:30AM	Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 (GlobeNewswire)
Mar-04-26 08:00AM	Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study (GlobeNewswire) +5.77%
Feb-02-26 07:32PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Jan-30-26 04:05PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
08:47AM	Loading…
Jan-12-26 08:47AM	Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer (GlobeNewswire)
Dec-17-25 04:11PM	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week (PR Newswire)
Dec-08-25 04:10PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Nov-25-25 08:40AM	FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation (Insider Monkey) +15.62%
Nov-06-25 04:01PM	Achieve Life Sciences Inc (ACHV) Q3 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
07:00AM	Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program (GlobeNewswire)
Nov-03-25 08:30AM	Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation (GlobeNewswire)
Oct-29-25 08:30AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 (GlobeNewswire)
Oct-22-25 03:31PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Oct-20-25 08:30AM	Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer (GlobeNewswire) +19.05%
08:25AM	FDA Grants First CNPV Vouchers, Igniting Rally in Biotech Stocks (GuruFocus.com)
Oct-17-25 04:21PM	The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. (Investor's Business Daily) +36.36%
07:30AM	Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation (GlobeNewswire)
Oct-02-25 04:01PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
Sep-22-25 08:30AM	Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline's Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD (GlobeNewswire)
Sep-18-25 08:30AM	Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer (GlobeNewswire)
Sep-11-25 05:01PM	Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer (GlobeNewswire)
Sep-03-25 08:30AM	Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
Sep-02-25 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +13.36%
Aug-21-25 02:11PM	Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years (Benzinga) +12.02%
Aug-07-25 07:30AM	Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program (GlobeNewswire)
Jul-29-25 08:30AM	Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference (GlobeNewswire) -5.20%
Jul-24-25 08:30AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025 (GlobeNewswire)
Jul-13-25 06:15AM	Raymond James Predicts Up to ~760% Surge for These 2 Strong Buy Stocks (TipRanks)
Jul-07-25 08:56AM	Should You Hold Achieve Life Sciences (ACHV)? (Insider Monkey) -5.05%
Jul-06-25 04:00AM	Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment (Insider Monkey)
Jun-30-25 07:52PM	Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities (GlobeNewswire)
Jun-26-25 11:43PM	Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering (GlobeNewswire) -7.63% -36.47%
04:03PM	Achieve Life Sciences Announces Proposed Underwritten Public Offering (GlobeNewswire)
04:02PM	Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades (GlobeNewswire)
04:01PM	Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
May-28-25 08:30AM	Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-25 08:30AM	Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake (GlobeNewswire)
May-14-25 03:06AM	Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -6.42%
01:56AM	Q1 2025 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:30AM	Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program (GlobeNewswire) +6.85%
May-06-25 08:30AM	Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 (GlobeNewswire) -6.25%
Apr-22-25 11:26AM	Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial (TipRanks) +10.22%
Apr-21-25 11:19AM	Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine (GlobeNewswire) +13.07%
Mar-20-25 06:25PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (InsiderMonkey)
Mar-12-25 03:14AM	Q4 2024 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -9.25%
03:02AM	Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Mar-11-25 07:30AM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program (GlobeNewswire)
Mar-07-25 08:30AM	Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference (GlobeNewswire)
Mar-06-25 08:30AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 (GlobeNewswire) +9.03%
Feb-18-25 07:29AM	Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) (Insider Monkey)
Feb-11-25 08:30AM	Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference (GlobeNewswire)
Feb-10-25 08:30AM	Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial (GlobeNewswire) +15.74%
Jan-24-25 12:14PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Jan-10-25 08:30AM	Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors (GlobeNewswire)
Jan-07-25 08:30AM	Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission (GlobeNewswire) +5.07%
Jan-06-25 08:30AM	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week (GlobeNewswire)
Jan-02-25 11:04AM	Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1? (Insider Monkey)
Dec-09-24 08:30AM	Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer (GlobeNewswire)
Dec-03-24 08:30AM	Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA (GlobeNewswire)
Nov-14-24 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 02:01PM	Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -7.40%
Nov-07-24 04:05PM	Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Oct-24-24 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 (GlobeNewswire)
Oct-23-24 08:00AM	Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting (GlobeNewswire)
Oct-16-24 08:00AM	Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline (GlobeNewswire)
Oct-10-24 08:00AM	Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting (GlobeNewswire)
Oct-01-24 08:45AM	Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs (GlobeNewswire)
Aug-26-24 04:30PM	Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors (GlobeNewswire)
Aug-13-24 04:01PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence (GlobeNewswire)
Jul-29-24 08:00AM	Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank (GlobeNewswire)
Jul-25-24 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stewart Richard Alistair	Director	Aug 19 '26	Sale	8.49	20,626	175,177	208,249	Aug 21 04:30 PM
Stewart Richard Alistair	Director	Aug 19 '26	Proposed Sale	7.52	20,626	155,108		Aug 19 09:16 AM

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Chief Legal OfficerMr. Erik Atkisson

CEODr. Andrew D. Goldberg M.D.

Chief Financial OfficerMr. Benjamin Halladay M.B.A.

VP of Finance & Principal Accounting OfficerMr. Jerry Wan

Senior Vice President of Marketing & CommunicationsMs. Kaitlyn Tuson

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Achieve Life Sciences Inc

Upgrade your Finviz experience